fbpx

The Team

Our team has extensive operational, business development and management experience from the industry and a large international network that we tap in to.

Lundbeckfonden Ventures

Mette Kirstine Agger

Mette Kirstine Agger

Managing Partner
Johan Kördel

Johan Kördel

Senior Partner
Casper Breum

Casper Breum

Senior Partner

Lundbeckfonden Ventures

News

BONESUPPORT HOLDING AB (publ) publishes Annual Report 2018
17. April 2019
BONESUPPORT will publish quarterly report earlier than previously communicated
16. April 2019
BONESUPPORTs annual report for 2018 is now available as a pdf on the group’s web page, www.bonesupport.com. A PDF-version is also attached to this press release. About BONESUPPORT™ BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden, and the net sales amounted to SEK 97 million in 2018. Please visit www.bonesupport.com for more information. BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB. For more information contact: BONESUPPORT AB Emil Billbäck, CEO +46 (0) 46 286 53 70 Håkan Johansson, CFO +46(0) 46 286 53 70 ir@bonesupport.com Cord Communications Charlotte Stjerngren +46 (0)708 76 87 87 charlotte.stjerngren@cordcom.se www.cordcom.se
15. April 2019